miR-21, a highly upregulated oncomiR, promotes tumour growth and drug resistance by suppressing genes such as phosphatase tensin homolog (PTEN) and programmed cell death 4 (PDCD4) [24]. The gene discussed is PTEN; the disease is neoplasm.